Company: BGLC
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001477932-25-008343
Chunk: 0

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
BIONEXUS GENE LAB CORP. 

CONDENSED CONSOLIDATED BALANCE SHEETS 

AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024  

(Currency expressed in United States Dollars (“US$”))

    As of   Note  September 30,  December 31,     2025  2024     (Unaudited)  (Audited) ASSETS         CURRENT ASSETS         Cash and bank balances     1,153,121   1,583,479 Fixed deposits placed with financial institutions (including $1,537,561 and $1,490,461 of fixed deposits with original maturities more than 3 months as of September 30, 2025 and December 31, 2024 respectively)     1,741,532   2,793,948 Trade receivables, net of allowance for credit losses of $671,777 and $517,877 as of September 30, 2025 and December 31, 2024 respectively (including $25,760 and $47,272 of trade receivables from related parties as of September 30, 2025 and December 31, 2024 respectively)  3   1,522,158   1,376,571 Other receivables, deposits and prepayments      98,903   203,660 Tax recoverable  4   103,640   84,167 Inventories  (including goods in transit of $190,588 and $188,797 as of September 30, 2025 and December 31, 2024 respectively)       1,007,448   1,388,624 Total current assets      5,626,802   7,430,449              NON-CURRENT ASSETS            Operating lease right-of-use assets  5   186,082   215,243 Property, plant and equipment, net  6   1,570,584   1,522,990 Investments in equity securities  7   237,760   1,265,166 Total non-current assets      1,994,426   3,003,399 TOTAL ASSETS     $7,621,228  $